Skip to main content
. 2017 Dec 19;5(12):2325967117745279. doi: 10.1177/2325967117745279

TABLE 1.

Patient Demographicsa

Overall (N = 163) Initial Cohort (n = 120) Validation Cohort (n = 43) P Value
Age, mean ± SD, y 16.7 ± 3.0 17.0 ± 2.9 16.0 ± 3.3 >.05
Weight, mean ± SD, kg 67.1 ± 16.4 67.6 ± 16.1 65.8 ± 17.6 >.05
Height, mean ± SD, cm 167.6 ± 11.1 168.5 ± 10.3 165.0 ± 12.9 >.05
Sex, female/male, n 105/58 78 /42 27 /16 >.05
Graft type, HS/BPTB/ALLO, n 95/53/15 60/49/11 35/4/4 <.001
Time from ACLR to RTS testing, mean ± SD, mo 8.3 ± 2.5 8.1 ± 2.1 8.9 ± 3.3 >.05

aACLR, anterior cruciate ligament reconstruction; ALLO, allograft; BPTB, bone–patellar tendon–bone graft; HS, hamstring graft; RTS, return to sport.